Osaka, Japan – June 11, 2026 – Sawai Pharmaceutical Co., Ltd. (Sawai, Head office: Osaka, Japan, President: Toshiomi Nakate) today announced the listing of six generic drugs with nine strengths in the NHI (National Health Insurance) drug price list. Sawai’s product line now includes 322 compounds with 748 strengths.
The list of new products
1. BILASTINE Tablets, OD Tablets
| Generic name |
Bilastine |
| Strengths |
Tablets, OD Tablets: 20mg |
| Brand products |
Bilanoa® tablets, OD tablets 20mg |
2. DESLORATADINE Tablets
| Generic name |
Desloratadine |
| Strengths |
Tablets: 5mg |
| Brand products |
DESALEX® Tablets 5mg |
3. ELTROMBOPAG Tablets
| Generic name |
Eltrombopag Olamine |
| Strengths |
Tablets: 12.5mg, 25mg |
| Brand products |
REVOLADE® Tablets 12.5mg, 25mg |
4. ANAGRELIDE Capsules
| Generic name |
Anagrelide Hydrochloride Hydrate |
| Strengths |
Capsules: 0.5mg |
| Brand products |
AGRYLIN® Capsules 0.5mg |
5. FESOTERODINE FUMARATE Sustained-release Tablets
| Generic name |
Fesoterodine Fumarate |
| Strengths |
Sustained-release Tablets: 4mg, 8mg |
| Brand products |
Toviaz® Tablets 4mg, 8mg |
6. FINGOLIMOD Capsules
| Generic name |
Fingolimod Hydrochloride |
| Strengths |
Capsules: 0.5mg |
| Brand products |
IMUSERA® Capsules 0.5mg, GILENYA® Capsules 0.5mg |
The products announced in this press release are not approved by the Food & Drug Administration for sale and distribution in the United States.
